Related Experiment Video

Updated: Sep 27, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Age-related Survival Outcomes for Pancreatic Cancer by Age

Ali Abbaszadeh Kasbi¹, Mohammed Ali Ashary¹, Mizba Baksh¹

¹Department of Surgery, Section of Surgical Oncology, Mayo Clinic in Florida, Jacksonville, FL, U.S.A.

Cancer Diagnosis & Prognosis

|April 11, 2022

Abstract

Background/Aim:

Pancreatic cancer has a very poor prognosis, though outcomes based on age are not well characterized. The aim of current study was to analyze the survival of patients with pancreatic cancer based on age.

Patients And Methods:

Using National Cancer Data Base (NCDB), we determined survival outcome based on age among patients with pancreatic cancer.

Results:

A total of 423,482 patients between 2004 and 2017 were included in the study. Patients aged between 18 and 40-years-old had the worst 3-year survival rate among stage 1 disease. Conversely, patients over 65-years-old had the worst 3-year survival rate and presented with more advanced disease (clinical stages 3 and 4).

Conclusion:

Older patients with more advanced disease had worse survival.

Keywords:

NCDB pancreatic cancer prognostic factors survival

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Articles linked to this work by shared authors, journal, and citation graph.

Regional Disparities in Socioeconomic Factors and Advanced-stage Presentation in Melanoma: A National Cancer Database Analysis (2004-2020).

Anticancer research·2026

Overall Survival After Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Patients With Three Recorded Positive Nodes: A National Cancer Database Analysis.

Clinical breast cancer·2026

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026

Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.

Cancer immunology research·2026

Case Report: durable response to pulsed electric field ablation in combination with immune checkpoint inhibitors in HER2-low breast cancer through activation of interferon signaling.

Frontiers in oncology·2026

See all related articles